The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 1,360 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
AEGERION PHARMACEUTICALS INC | COM | 00767E102 | 680 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ALBANY MOLECULAR RESH INC | COM | 012423109 | 7,010 | 402,400 | SH | SOLE | 402,400 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 221 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 2,718 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ALLIQUA BIOMEDICAL INC | COM NEW | 019621200 | 1,335 | 421,000 | SH | SOLE | 421,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 772 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
ANI PHARMACEUTICALS INC | COM | 00182C103 | 988 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
ANI PHARMACEUTICALS INC | COM | 00182C103 | 12,446 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
APRICUS BIOSCIENCES INC | COM | 03832V109 | 146 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
APRICUS BIOSCIENCES INC | COM | 03832V109 | 949 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 292 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 6,364 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CRYOLIFE INC | COM | 228903100 | 3,600 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 669 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FIBROCELL SCIENCE INC | COM NEW | 315721209 | 569 | 147,769 | SH | SOLE | 147,769 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 3,845 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
MANNKIND CORP | COM | 56400P201 | 3,852 | 1,200,000 | SH | Put | SOLE | 1,200,000 | 0 | 0 | |
MYLAN N V | SHS EURO | N59465109 | 2,013 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
PFIZER INC | COM | 717081103 | 4,712 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
PROSHARES TR | ULTSHT RUSS2000 | 74348A319 | 2,169 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROSHARES TR | ULTSHT RUSS2000 | 74348A319 | 2,169 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
QLT INC | COM | 746927102 | 5,738 | 2,157,200 | SH | SOLE | 2,157,200 | 0 | 0 | ||
QUEST DIAGNOSTICS INC | COM | 74834L100 | 4,070 | 66,208 | SH | SOLE | 66,208 | 0 | 0 | ||
SORRENTO THERAPEUTICS INC | COM NEW | 83587F202 | 420 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
STEMLINE THERAPEUTICS INC | COM | 85858C107 | 221 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM NEW | 867328601 | 365 | 450,000 | SH | Call | SOLE | 450,000 | 0 | 0 | |
ZOGENIX INC | COM NEW | 98978L204 | 430 | 31,850 | SH | SOLE | 31,850 | 0 | 0 |